iStock-1251514307.jpg

HEALTH INNOVATION AND THE ENTREPRENEUR

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

CATEGORY: FUTURE OF HEALTH    CLIENT: ARRINEX    DATE: 01.02.2020

THE CHALLENGE

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

THE OUTCOME

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Add a Title
Add a Title

Describe your image

press to zoom
Add a Title
Add a Title

Describe your image

press to zoom
Add a Title
Add a Title

Describe your image

press to zoom
Add a Title
Add a Title

Describe your image

press to zoom
1/12

Arrinex, a start-up based in the Bay Area, created a unique solution for allergic rhinitis: minimally invasive cryotherapy that directly inhibits the neural pathway triggering the allergic response. The science was sound, but a key challenge was developing an entirely novel device for a novel procedure that was without precedent. Future Medical Systems rapidly refined the initial surgical handset interaction design and met with future users to understand their processes and needs.

 

FMS held device feedback and co-design sessions with clinicians, even turning a conference room into a makeshift ENT clinic. Using modelling clay, wire and wooden dowels, clinicians were able to practice manipulating the device, prototyping new handset forms and physical interfaces in real-time. One outcome of this was to 

re-architect the handset, ultimately creating an intuitive interface between the probe tip and the user’s hand.We further worked hand-in-hand with the device engineering team, prioritizing and addressing critical user needs throughout the intervention process, including developing training support materials.

 

Following excellent clinical results and FDA 510(k) clearance, Arrinex was purchased by Stryker in 2019, representing a positive outcome for the team.